Notice type: 3rd Party Publications
Date: 12/04/2024
The Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines. Its recommendations are considered by the Committee for Medicinal Products for Human Use (CHMP) when it adopts opinions for centrally authorised medicines and referral procedures and by the Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) when it provides a recommendation on the use of a medicine in Member States. Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 April 2024 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 4-7 March 2024 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 5-8 February 2024 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 08-11 January 2024 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 28-30 November 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 23-26 October 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 25-28 September 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 28-31 August 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3-6 July 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 5-8 June 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 10-12 May 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 11-14 April 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 13-16 March 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 6-9 February 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 9-12 January 2023 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 28 November - 1 December 2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 24-27 October 2022
Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 26-29 September 2022
Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 29 August -1 September 2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 4-7 July 2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 7-10 June 2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 2-5 May 2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 4-7 April 2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 7-10 March 2022 Pharmacovigilance Risk Assessment Commitee (PRAC) Meeting Highlights 7-10 February 2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 10-13 January 2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 29 November -2 December 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 25-28 October 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 27-30 September 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 30 August -2 September 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 5-8 July 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 7-10 June 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3-6 May 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 6-9 April 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 March 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 February 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 11-14 January 2021 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 23-26 November 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 26-29 October 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 28 September - 1 October 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 31 Aug - 3 September 2020 Pharmacovigilace Risk Assessment Committee (PRAC) Meeting Highlights 6-9 July 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 June 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 11-14 May 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 14-17 April 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 9-12 March 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 10-13 February 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 13-16 January 2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 25-28 November 2019
Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 28-31 October 2019
Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 30 Sept - 3 October 2019 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 2-5 September 2019 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 July 2019 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 11-14 June 2019 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 13-16 May 2019 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 April 2019 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 12-15 March 2019 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 11-14 February 2019 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 14-17 January 2019